Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from Moderna

Cancer and heart disease vaccines ‘ready by end of the decade’

Exclusive: Pharmaceutical firm says groundbreaking jabs could save millions of lives

The Guardian - UK

Being Vaccinated Halves Risk Of Long COVID: Study

It was based on 860,000 patients across the world. The post Being vaccinated halves risk of long COVID: study appeared first on Talker.

Zenger

Lisa Jarvis: An urgently needed TB shot could democratize vaccines

Tuberculosis surrendered the title of the world’s deadliest infectious disease after COVID-19 struck, but it reclaimed that terrible distinction last year. As with COVID, a new vaccine could go a long way to sharply curtailing the disease, which killed about 1.4 million people a year before the pandemic and increased…

Tribune News Service

From analysis to the latest developments in health,
read the most diverse news in one place.

Sen. Bernie Sanders shows fire, but seeks modest goals, in his debut drug hearing as health chair

Sen. Bernie Sanders, who rose to national prominence criticizing big business in general and the pharmaceutical industry in particular, claimed the spotlight Wednesday on what might at first seem a powerful new stage from which to advance his agenda: chairmanship of the Senate health committee.

Tribune News Service

Michael Hiltzik: Biden says he wants to bring down drug prices. His actions tell a different story

You might get the impression from the Biden administration's insulin price cut and its initiative allowing Medicare to negotiate over other pharmaceuticals that the drug pricing issue is finally being taken seriously in Washington.

Los Angeles Times

Photos of the week ending March 24, 2023 - Roll Call

Photos of the week: Congress returned to Washington for a shortened work week this week.

Roll Call

Moderna CEO grilled by Senate panel over planned price hike

WASHINGTON — Moderna CEO Stéphane Bancel attempted on Wednesday to win over lawmakers irate about the company’s planned COVID-19 vaccine price increase, weathering a barrage of criticism from Democrats angry at the company’s profits from its groundbreaking mRNA vaccine.

Tribune News Service

Read news from The Economist, FT, and more,
with one subscription

Senators press Moderna CEO on COVID-19 vaccine price hike

Moderna’s CEO is defending a plan to more than quadruple the company’s COVID-19 vaccine price

The Independent UK

Sunak’s tax return: the questions that remain unanswered

Details of his blind management arrangement and what offshore interests the prime minister has are still unclear

The Guardian - UK

Moderna faces criticism as it prices COVID vaccine at $130 per dose

Pfizer has said it’s considering a similar price for its vaccine.

Fortune

Moderna CEO grilled by Senate panel over planned price hike - Roll Call

In a Senate hearing, Moderna's CEO tried to soothe lawmakers angry about plans to increase the cost of COVID-19 vaccines.

Roll Call

Moderna paid the US more than enough for COVID shot partnership, executive says

WASHINGTON — Moderna Inc. plans to tell U.S. lawmakers that it more than adequately compensated the government for its role in a COVID-19 vaccine partnership that brought the drugmaker billions of dollars, a central point in what’s likely to be a heated Capitol Hill hearing this week.

Tribune News Service

Sanders: "Medicare for All" must wait

As new chairman of the Senate HELP Committee, Sanders maps out his strategy for negotiating with GOP and Big Pharma

Salon

Moderna's COVID vaccine gambit: Hike the price, offer free doses for uninsured

Once U.S. stockpiles of COVID-19 vaccine run out, Moderna says it might charge as much as $130 per dose, but give people who lack health insurance a break. Critics say that's not enough help.

WEKU

Get all your
news in one place.

100's of premium titles.
One news app.

The Conversation

What are these 'cancer vaccines' I'm hearing about? And what similarities do they share with COVID vaccines?

Barely a month goes by without headlines announcing yet another advancement in cancer vaccines.

The New Daily

What are these ‘cancer vaccines’ making news? Are there similarities with COVID vaccines?

Using the same mRNA technology as COVID vaccines, cancer vaccines are an emerging personalised treatment for cancer.

Fortune

Moderna eyes testing of mpox, bird flu vaccines in humans this year: 'They're really for public health'

A shot against mpox would be valuable in case outbreaks reemerge, and the company sees bird flu as a “clear threat,” the company's president said.

Birmingham Post

Cramlington's Merit enlisted for £150m Moderna vaccine hub scheme

Hundreds of construction jobs will be created through the Moderna Innovation and Technology Centre (MITC) project

Get all your
news in one place.

100's of premium titles.
One news app.

The Conversation

Is there a vaccine for RSV or respiratory syncytial virus? After almost 60 years, several come at once

You might not have heard of respiratory syncytial virus, or RSV. But it caused more than 100,000 global deaths in 2019, making it a leading cause of death in children under one year old.

ABC News

A new bivalent COVID-19 booster rolls out next month. Here's what you need to know about the vaccine

All Australian adults who haven't had a COVID-19 booster or a confirmed case in the past six months are now eligible for an additional shot.

ABC News

Risk of COVID death or hospitalisation 88 per cent lower for those previously infected, study finds

One of the largest studies conducted on COVID immunity finds that previous infections provide protection for as long as vaccination, but experts caution vaccines are still the safer option.

The Independent UK

Moderna, Pfizer and BioNTech Covid vaccine patent dispute heads to 2024 trial

US firm Moderna is suing its competitors for alleged patent infringement in relation to their Comirnaty vaccine.

Tribune News Service

Moderna won’t raise price on COVID vaccine after pressure

Moderna said Wednesday it wouldn’t raise the price of its COVID-19 vaccine after a public outcry.

Reuters

U.S. backs Moderna, says government should face COVID-19 vaccine lawsuit

The U.S. government should face a patent lawsuit over COVID-19 vaccines, not vaccine maker Moderna Inc, the Department of Justice told a Delaware federal court on Tuesday.

Tribune News Service

Q&A: Why Bernie Sanders says his ‘Medicare for All’ dream must wait

After railing at the injustices of U.S. health care for decades, Sen. Bernie Sanders in January became the new chairman of the Senate Health, Education, Labor & Pensions Committee. The job gives the health care industry’s biggest Washington nemesis an unprecedented opportunity to shape health care reform in Congress. But…

1 … 11 12 13 14

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Department of Justice

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.